Clinical Trial Update: Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 2]

View source ↗

Summary

Phase 2 results and safety data for Losmapimod in patients with Facioscapulohumeral Muscular Dystrophy have been posted after the study completed. The trial was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• Losmapimod (losmapimod)

Snippet

Sponsor: Fulcrum Therapeutics | Conditions: Facioscapulohumeral Muscular Dystrophy (FSHD) | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10